Korea's Antitrust Watchdog Says Rebates Continuing Despite New Law; Levies $11 Million In Fines
This article was originally published in PharmAsia News
Executive Summary
SEOUL - South Korea's antitrust watchdog the Fair Trade Commission said rebates by both multinational and local Korean pharmaceutical companies are continuing even though doctors can be punished for accepting rebates under a new law that took effect late last year